Page 1 | Search Results | Blood Advances | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM

Blood Adv (2024) 8 (11): 2890–2900.

https://doi.org/10.1182/bloodadvances.2024012756

Published: 2024

Includes: Supplemental data

Journal Articles

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1 , GATA2 , and DDX41

Claire C. Homan, Michael W. Drazer, Kai Yu, David M. Lawrence, Jinghua Feng, Luis Arriola-Martinez, Matthew J. Pozsgai, Kelsey E. McNeely, Thuong Ha, Parvathy Venugopal, Peer Arts, Sarah L. King-Smith, Jesse Cheah, Mark Armstrong, Paul Wang, Csaba Bödör, Alan B. Cantor, Mario Cazzola, Erin Degelman, Courtney D. DiNardo, Nicolas Duployez, Remi Favier, Stefan Fröhling, Ana Rio-Machin, Jeffery M. Klco, Alwin Krämer, Mineo Kurokawa, Joanne Lee, Luca Malcovati, Neil V. Morgan, Georges Natsoulis, Carolyn Owen, Keyur P. Patel, Claude Preudhomme, Hana Raslova, Hugh Rienhoff, Tim Ripperger, Rachael Schulte, Kiran Tawana, Elvira Velloso, Benedict Yan, Erika Kim, Raman Sood, Amy P. Hsu, Steven M. Holland, Kerry Phillips, Nicola K. Poplawski, Milena Babic, Andrew H. Wei, Cecily Forsyth, Helen Mar Fan, Ian D. Lewis, Julian Cooney, Rachel Susman, Lucy C. Fox, Piers Blombery, Deepak Singhal, Devendra Hiwase, Belinda Phipson, Andreas W. Schreiber, Christopher N. Hahn, Hamish S. Scott, Paul Liu, Lucy A. Godley, Anna L. Brown

Blood Adv (2023) 7 (20): 6092–6107.

https://doi.org/10.1182/bloodadvances.2023010045

Published: 2023

Includes: Supplemental data

Journal Articles

Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study

Blood Adv (2023) 7 (12): 2772–2783.

https://doi.org/10.1182/bloodadvances.2022008360

Published: 2023

Includes: Supplemental data

Journal Articles

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Vanessa E. Kennedy, Cecelia Perkins, Andreas Reiter, Mohamad Jawhar, Johannes Lübke, Hanneke C. Kluin-Nelemans, William Shomali, Cheryl Langford, Justin Abuel, Olivier Hermine, Marek Niedoszytko, Aleksandra Gorska, Andrzej Mital, Patrizia Bonadonna, Roberta Zanotti, Ilaria Tanasi, Mattias Mattsson, Hans Hagglund, Massimo Triggiani, Akif Selim Yavuz, Jens Panse, Deborah Christen, Marc Heizmann, Khalid Shoumariyeh, Sabine Müller, Chiara Elena, Luca Malcovati, Nicolas Fiorelli, Friederike Wortmann, Vladan Vucinic, Knut Brockow, Christos Fokoloros, Sotirios G. Papageorgiou, Christine Breynaert, Dominique Bullens, Michael Doubek, Anja Ilerhaus, Irena Angelova-Fischer, Oleksii Solomianyi, Judit Várkonyi, Vito Sabato, Axel Rüfer, Tanja Daniela Schug, Maud A. W. Hermans, Anna Belloni Fortina, Francesca Caroppo, Horia Bumbea, Theo Gulen, Karin Hartmann, Hanneke Oude Elberink, Juliana Schwaab, Michel Arock, Peter Valent, Wolfgang R. Sperr, Jason Gotlib

Blood Adv (2023) 7 (9): 1713–1724.

https://doi.org/10.1182/bloodadvances.2022008292

Published: 2023

Includes: Supplemental data

Journal Articles

Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals

Isabelle A. van Zeventer, Aniek O. de Graaf, Theresia N. Koorenhof-Scheele, Bert A. van der Reijden, Melanie M. van der Klauw, Avinash G. Dinmohamed, Arjan Diepstra, Jan Jacob Schuringa, Luca Malcovati, Gerwin Huls, Joop H. Jansen

Blood Adv (2022) 6 (14): 4174–4184.

https://doi.org/10.1182/bloodadvances.2021006755

Published: 2022

Includes: Supplemental data

Journal Articles

Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1 -mutant HSPCs

Georgios Asimomitis, André G. Deslauriers, Andriana G. Kotini, Elsa Bernard, Davide Esposito, Malgorzata Olszewska, Nikolaos Spyrou, Juan Arango Ossa, Teresa Mortera-Blanco, Richard Koche, Yasuhito Nannya, Luca Malcovati, Seishi Ogawa, Mario Cazzola, Stuart A. Aaronson, Eva Hellström-Lindberg, Elli Papaemmanuil, Eirini P. Papapetrou

Blood Adv (2022) 6 (10): 2992–3005.

https://doi.org/10.1182/bloodadvances.2021006325

Published: 2022

Includes: Supplemental data

Journal Articles

A geno-clinical decision model for the diagnosis of myelodysplastic syndromes

Blood Adv (2021) 5 (21): 4361–4369.

https://doi.org/10.1182/bloodadvances.2021004755

Published: 2021

Includes: Supplemental data

Journal Articles

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Isabelle A. van Zeventer, Aniek O. de Graaf, Melanie M. van der Klauw, Edo Vellenga, Bert A. van der Reijden, Jan Jacob Schuringa, Arjan Diepstra, Luca Malcovati, Joop H. Jansen, Gerwin Huls

Blood Adv (2021) 5 (17): 3266–3278.

https://doi.org/10.1182/bloodadvances.2021004355

Published: 2021

Includes: Supplemental data

Journal Articles

A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS

Blood Adv (2021) 5 (16): 3066–3075.

https://doi.org/10.1182/bloodadvances.2020004055

Published: 2021

Journal Articles

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis

Blood Adv (2021) 5 (5): 1452–1462.

https://doi.org/10.1182/bloodadvances.2020003614

Published: 2021

Includes: Supplemental data

Journal Articles

Guideline-based indicators for adult patients with myelodysplastic syndromes

Blood Adv (2020) 4 (16): 4029–4044.

https://doi.org/10.1182/bloodadvances.2020002314

Published: 2020

Includes: Supplemental data

Journal Articles

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

Blood Adv (2019) 3 (20): 2962–2979.

https://doi.org/10.1182/bloodadvances.2019000644

Published: 2019

Includes: Supplemental data

Journal Articles

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Blood Adv (2018) 2 (16): 2079–2089.

https://doi.org/10.1182/bloodadvances.2018020495

Published: 2018

Includes: Supplemental data

NARROW

Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1 , GATA2 , and DDX41

Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals

Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1 -mutant HSPCs

A geno-clinical decision model for the diagnosis of myelodysplastic syndromes

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis

Guideline-based indicators for adult patients with myelodysplastic syndromes

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only